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Abstract
Background: Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular
matrix of the intervertebral disc. A SNP for guanine insertion/deletion (G/D), the -1607 promoter
polymorphism, of the MMP1 gene was found significantly affecting promoter activity and corresponding
transcription level. Hence it is a good candidate for genetic studies in DDD.
Methods: Southern Chinese volunteers between 18 and 55 years were recruited from the population.
DDD in the lumbar spine was defined by MRI using Schneiderman's classification. Genomic DNA was
isolated from the leukocytes and genotyping was performed using the Sequenom® platform. Association
and Hardy-Weinberg equilibrium checking were assessed by Chi-square test and Mann-Whitney U test.
Results: Our results showed substantial evidence of association between -1607 promoter polymorphism
of MMP1 and DDD in the Southern Chinese subjects. D allelic was significantly associated with DDD (p
value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–1.90) while Genotypic association on the presence
of D allele was also significantly associated with DDD (p value = 0.046, odds ratio = 1.50 with 95% CI =
1.01–2.24). Further age stratification showed significant genotypic as well as allelic association in the group
of over 40 years (genotypic: p value = 0.035, odds ratio = 1.617 with 95% CI = 1.033–2.529; allelic: p value
= 0.033, odds ratio = 1.445 with 95% CI = 1.029–2.029). Disc bulge, annular tears and the Schmorl's nodes
were not associated with the D allele.
Conclusion: We demonstrated that individuals with the presence of D allele for the -1607 promoter
polymorphism of MMP1 are about 1.5 times more susceptible to develop DDD when compared with
those having G allele only. Further association was identified in individuals over 40 years of age. Disc bulge,
annular tear as well as Schmorl's nodes were not associated with this polymorphism.
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Low back pain (LBP) affects 70% to 80% of all people at
some time during their life [1]. The annual prevalence
ranges from 15% to 45%, with a point prevalence averag-
ing 30% [1]. Degenerative Disc Disease (DDD) in the
lumbar spine or lumbar disc degeneration is a major cause
of LBP [2-7].
Up to now, there is only a limited understanding of DDD,
with the underlying pathophysiological and molecular
mechanisms remain un-elucidated. Studies suggested that
environmental factors such as physical loading, motor
vehicle driving, vibration and smoking may have a role [8-
11]. However, there is increasing evidence that DDD is a
genetic disorder [12], with reports of predisposition in
association with certain genes, such as Taq I polymor-
phism of vitamin D receptor (VDR) gene [2,5,13,14], pol-
ymorphism of metalloproteinase-3 (MMP3) gene [15-
17], mutations in collagen IX genes (COL9A2 and
COL9A3) [18-22], Sp1 polymorphism of collagen I gene
(COL1A1) [23,24], polymorphism of cartilage intermedi-
ate layer protein (CILP) [25] as well as aggrecan gene pol-
ymorphism [26]. The involvement of multiple genes is
not uncommon, as aetiology is often multifactorial in
common diseases such as DDD [12].
In the process of disc degeneration, degradation of the
extracellular matrix (ECM) is a key event. Collagens are
one of the major constituents of the ECM. They make up
20% dry mass of the nucleus pulposus and 60% dry mass
of the annulus fibrosis. Approximately 80% of the colla-
gens in the intervertebral disc consist of fibrillar collagen
types I and II [16,27]. Matrix metalloproteinases (MMPs)
are the family of degradation enzymes that break down
the components of the ECM [17,27,28]. In particular,
MMP1 is a collagenase which cleaves the triple helical part
of the fibrillar collagen of types I, II and III, and is pro-
posed to initiate the degradation process [29-35]. The
cleaved fragments have a lower melting temperature than
37°C, which are then further cleaved by other MMPs.
Similarly, MMP1 can cleave aggrecan at the major MMP
cleavage sites between the G1 and G2 domains contribut-
ing to the breakdown of aggrecan [36].
Expression of MMPs is generally low in normal cells
which allows for healthy tissue turnover. On the other
hand, the level of MMPs increases substantially under
pathological conditions and results in ECM degradation.
A single nucleotide polymorphism (SNP) for guanine
insertion/deletion (G/D) at position -1607 in the pro-
moter region of the MMP1 gene (-1607 polymorphism)
results in creation of binding sites for Ets transcription fac-
tor family [29]. Upon the interaction of adjacent AP-1 site,
the promoter activity and hence the transcription level of
MMP1 can be considerably increased [29,30].
In the present study, the association between this pro-
moter SNP and DDD was investigated in a population-
based dataset [14,22]. We demonstrated significant asso-
ciation with DDD and the deletion of guanine is sug-
gested to be a possible genetic risk factor predisposing to
DDD.
Methods
Subjects & assessment
The study was approved by the local ethics committee and
informed consent was obtained. Individuals of Southern
Chinese origin were recruited by open invitation from the
general population. All the recruited subjects subse-
quently underwent magnetic resonance imaging (MRI) of
the lumbar spine and their blood was obtained for DNA
extraction and genotyping analysis.
The MRI examinations were performed at the Jockey Club
MRI Engineering Centre using a 0.2T Profile open MRI
system (General Electric Medical System, Milwaukee, WI).
Sagittal T2-weighted fast spin echo sequences (TR = 3000
ms, TE = 92 ms, slice thickness = 5 mm) were used to
image the lumbar spine with a built-in flexible body coil.
Despite the relative low field, previous studies have dem-
onstrated this to be sensitive enough to identify abnor-
malities associated with DDD [14,22].
DDD was diagnosed on the basis of signal intensity
changes within the nucleus pulposus (NP) of the interver-
tebral discs (IVDs) of the lumbar spine and graded using
the Schneiderman's classification scheme [37]. Grade 0
was used to indicate normal disc with hyperintense signal
within the NP, grade 1 for a slight decrease in signal inten-
sity in the NP, grade 2 for a generalized hypointense NP
and grade 3 for a hypointense NP with disc space narrow-
ing. All the MRI scans were analyzed and rated by two
experienced physicians blinded to the results of the
genetic analysis and clinical history. Differences were
reviewed by the two raters and settled by consensus. The
score for each disc (0–3) was then summated to create a
DDD score for the whole lumbar spine (0–15) as previ-
ously described [14]. To define the affection status using
DDD score, a score of 0 was used to indicate the absence
of disc degeneration, while a score of 2 or above was used
to indicate the presence of degeneration. Individuals with
DDD score of 1 are considered as borderline degeneration
and was the area of the majority of disagreements between
the 2 raters and hence those with DDD score of 1 was con-
sidered unknown affection status and excluded from anal-
ysis [14,22].
Disc bulge was defined in discs where it has protruded
posteriorly beyond a line connecting the posterior mar-
gins of the adjacent vertebral bodies. In addition, annular
tears and Schmorl's nodes were assessed [14]. AnnularPage 2 of 6
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the posterior annulus surrounded by a dark rim.
Schmorl's nodes were defined as areas of endplate irregu-
larities in which the darkened rim of the vertebral end-
plate has indented into the vertebral body.
SNP genotyping
Genomic DNA was isolated from the leukocytes and the
quality as well as quantity measured by spectrophotome-
try. Genotyping was performed using the Sequenom® plat-
form. The Mass ARRAY AssayDesign software
(Sequenom) was used to design amplification and allele-
specific extension primers. The extension primer (5'-
GTAGTTAAATAATTAGAAAG-3') was designed to hybrid-
ize to the amplicon near the SNP site for the extension of
a single base or a few bases depending on the genotype of
the allele. PCR reactions (Forward primer: 5'-ACGTT-
GGATGGAACTCACATGTTATGCCAC-3'; Reverse-primer:
5'-ACGTTGGATGCTTCAGTATATCTTGGATTG-3') were
set up in 384-well plates at 6 µL total volume per reaction
and the reaction mix contains: 5 ng genomic DNA, 0.3
pmol each of specific forward and reverse primers, 200
µM of each dNTP, 3.25 mM MgCl2 and 0.2 unit of Hot-
StarTaq polymerase (5U/µL, Qiagen, Valencia, CA). The
PCR condition was: 95°C for 15 min, 45 cycles of 95°C
for 20 sec, 56°C for 30 sec and 72°C for 1 min, followed
by 72°C for 3 min. The treatment of PCR products with
alkaline phosphatase and mass extend reactions were all
performed according to manufacturer's (Sequenom) pro-
tocol. The final base-extension products were desalted
using SpectroClean resin (Sequenom), mixed with 3-
hydroxypicolinic acid and analyzed using a modified
Brucker Autoflex MALDI-TOF mass spectrometer
(Brucker, Billerica, MA).
Statistical analysis
Association and Hardy-Weinberg equilibrium checking
were assessed by χ2 test and Mann-Whitney U test. Odds
ratios and other statistical measures were calculated by
SPSS 14.0 software.
Results
A total of 691 individuals were genotyped for the study
with 266 males and 425 females. In common with previ-
ous studies, no significant differences could be detected in
disease predisposition between the 2 genders and there-
fore no gender stratification was carried out [11,13,14].
Analysis of the D allele showed an over representation in
the case group. The D allele conferred a higher risk (1.4
times) of developing DDD when compared to the G allele
(P-value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–
1.90) (Table 1). Genotypic association on the presence of
the D allele was also significantly associated with DDD (P-
value = 0.046, odds ratio = 1.50 with 95% CI = 1.01–2.24)
(Table 2).
Because DDD is age related and 2 risk factors, VDR [14]
and the COL9A2 [22], have previously been demonstrated
to be age-dependent, we also analyzed this MMP1 associ-
ation to DDD stratified by age group. Using a stratifica-
tion as in a previous study [14], no significant association
was detected in an under-40-year age group (P-value = 0.5,
OR = 1.26 with 95% CI = 0.64–2.46). However, in the
over-40-year age group, the association was significant (P-
value = 0.03, OR = 1.46 with 95% CI = 1.03–2.03) (Tables
1 &2).
In addition, we assessed the difference in the distribution
of the DDD score for the D-allele+ (either DD or DG gen-
otype) and D-allele- (GG genotype) groups by Mann-
Whitney U test. It was found that the distribution of the
DDD score was significantly different between the D-
allele+ and D-allele- groups (p value = 0.028) with D-
allele+ group having higher DDD score.
Apart from DDD, association was tested on disc bulge,
annular tear as well as Schmorl's nodes, no significant
association with these phenotypes were found with the
MMP1 promoter polymorphism (Table 3).
Discussion
This is the first report of an association of a SNP in the
promoter region of MMP1 with DDD. DDD is a complex
multifactorial disease. It has been suggested that disc
degeneration is highly correlated to age [15,38-41] and
age stratification was performed in previous studies
[14,22]. Our results indicated that the association of DDD
Table 1: Allelic association of DDD with the -1607 polymorphism of MMP1
Total Age ≤ 40 Age > 40
G (%) D (%) G (%) D (%) G (%) D (%)
Control 170 (69.7) 74 (30.3) 31 (67.4) 15 (32.6) 139 (70.2) 59 (29.8)
Case 593 (62.0) 363 (38.0) 143 (62.2) 87 (37.8) 450 (62.0) 276 (38.0)
OR (95% CI) 1.41 (1.04–1.90) 1.26 (0.64–2.46) 1.46 (1.03–2.03)
p value 0.027 0.503 0.033
Note: The G allele is the reference allele of the calculation of ORs.Page 3 of 6
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jects over 40 years of age.
MMP1 is involved in the cleavage of fibrillar collagens I, II
and III [29-35]. Type I collagen is found extensively within
the annulus fibrosus and bony end-plate, while Type II is
the predominant collagen in the inner annulus, nucleus
pulposus as well as the cartilaginous end-plate [16,27].
Previous studies in tumor cell lines showed that an over-
representation of the G allele of this promoter SNP
resulted in increased MMP1 transcriptional activity, hence
more aggressive matrix degradation [29]. This was pro-
posed to be a mechanism in cancer progression and was
proven in subsequent functional studies which showed
that the G allele created additional binding sites for the Ets
family of transcription factors [29]. These Ets binding sites
(-1607 bp) work cooperatively with a nearby AP-1 site (-
1602 bp) to enhance promoter activity by at least 2 folds
[29,30]. With the increased promoter activity and hence
transcription level, the presence of the G allele could con-
sider to be risk factor for matrix degradation.
Although we found an association with this promoter
SNP in MMP1, our result showed the presence of the D
allele resulted in an increased risk of DDD, and not the
anticipated G allele. Previous in vitro studies have shown
that the G allele is associated with higher expression levels
of MMP1 [29,30]. Thus, individuals with the D allele with
increase risk for DDD could not be explained by increased
susceptibility to matrix degradation because there is no
over-expression of MMP1.
This association may be explained in a number of ways.
First, the frequency for D allele is high in different ethnic
populations with 62.5% and 56.7% for African and Cau-
casian respectively (NCBI database), and 36.4% for
Southern Chinese. The high frequency of D allele may
indicate that the D allele is a common ancestor allele,
which might be in linkage disequilibrium with unknown
disease-causing polymorphism within the same gene. Sec-
ondly, MMP1 is located in a gene cluster on chromosome
11 with other MMP genes (MMP-3, 7, 8, 10, 12, 13, 20
and 26). It is possible that the observed association is the
result of linkage disequilibrium between this MMP1 pro-
moter polymorphism and polymorphisms in other
nearby MMP genes. Moreover, despite the Ets binding site
can cooperate with AP-1 site to enhance transcription of
MMP1, this polymorphism has yet to be tested in interver-
tebral disc tissues, to see whether it affects the transcrip-
tion level of MMP1. It maybe that gene expression be
differentially displayed in a tissue-specific manner. In
addition, expressional activity of MMP1 may also be influ-
enced differentially in response to cytokines and growth
factors. Even in the case of cancer, allele corresponding to
elevated MMP1 activity (expected to have increased sus-
ceptibility to cancer and poor prognosis) was unexpect-
edly found to have favourable prognosis with colorectal
cancer and no association with tumor characteristics [42].
Thus further replications of association in other ethnic
populations would help substantiate findings in this
study.
Conclusion
In summary, we have performed a case-control associa-
tion study to test for association between this promoter
SNP (-1607 polymorphism) of MMP1 and DDD. We have
demonstrated this promoter polymorphism was signifi-
cantly associated with increased susceptibility to DDD in
our Southern Chinese population, especially in individu-
als over 40 years of age. Disc bulge, annular tear as well as
Schmorl's nodes were not associated with this polymor-
phism.
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Table 2: Genotypic association of LDD with the -1607 polymorphism of MMP1
Total Age ≤ 40 Age > 40
GG (%) DD/DG (%) GG (%) DD/DG (%) GG (%) DD/DG (%)
Control 58 (47.5) 64 (52.5) 9 (39.1) 14 (60.9) 49 (49.5) 50 (50.5)
Case 180 (37.7) 298 (62.3) 43 (37.4) 72 (62.6) 137 (37.7) 226 (62.3)
OR (95% CI) 1.50 (1.01–2.24) 1.08 (0.43–2.70) 1.62 (1.03–2.53)
p value 0.046 0.875 0.035
Note: The GG genotype is reference genotype of the calculation of ORs.
Table 3: Genotypic association of other degenerative changes 
with the -1607 polymorphism of MMP1
GG (%) DD/DG (%) p value
Disc bulge Control 122 (42.7) 164 (57.3) 0.316
Case 113 (38.6) 180 (61.4)
Annular tear Control 215 (41.0) 309 (59.0) 0.430
Case 55 (37.4) 92 (62.6)
Schmorl's node Control 239 (40.0) 358 (60.0) 0.758
Case 31 (41.9) 43 (58.1)Page 4 of 6
(page number not for citation purposes)
BMC Medical Genetics 2008, 9:38 http://www.biomedcentral.com/1471-2350/9/38Authors' contributions
YQ, DW, PYP and BJ carried out molecular studies. YQ,
DW and KMC drafted the manuscript. JK, KMC, KDK and
JCY carried out clinic studies. DW, SPY and PS performed
the statistical analysis. YQ, KSE, DC and KMC conceived
of the study, and participated in its design and coordina-
tion. All authors read and approved the final manuscript.
Acknowledgements
The authors thank Pei Yu, Woo Yuk Kuen, Mavis Yiu, and Iris Lee for their 
expert technical assistance. The authors also thank The Hong Kong Jockey 
Club MRI Center and the Genome Research Centre, The University of 
Hong Kong for the use of their facilities. This work was supported by grants 
from the University Grants Committee of Hong for Kong (AoE/M-04/04) 
and the Research Grants Council of Hong Kong (HKU7509/03 M).
References
1. Andersson GB: Epidemiological features of chronic low-back
pain.  Lancet 1999, 354:581-585.
2. Kawaguchi Y, Kanamori M, Ishihara H, Ohmori K, Matsui H, Kimura
T: The association of lumbar disc disease with vitamin-D
receptor gene polymorphism.  J Bone Joint Surg Am 2002, 84-
A(11):2022-2028.
3. Salminen JJ, Erkintalo MO, Pentti J, Oksanen A, Kormano MJ: Recur-
rent low back pain and early disc degeneration in the young.
Spine 1999, 24:1316-1321.
4. Rannou F, Revel M, Poiraudeau S: Is degenerative disk disease
genetically determined?  Joint Bone Spine 2003, 70:3-5.
5. Videman T, Leppavuori J, Kaprio J, Battie MC, Gibbons LE, Peltonen
L, Koskenvuo M: Intragenic polymorphisms of the vitamin D
receptor gene associated with intervertebral disc degenera-
tion.  Spine 1998, 23:2477-2485.
6. Deyo RA, Weinstein JN: Low back pain.  N Engl J Med 2001,
344:363-370.
7. Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW: Fibronectin and
its fragments increase with degeneration in the human
intervertebral disc.  Spine 2000, 25:2742-2747.
8. Kelsey JL, Githens PB, O'Conner T, Weil U, Calogero JA, Holford TR,
White AA 3rd, Walter SD, Ostfeld AM, Southwick WO: Acute pro-
lapsed lumbar intervertebral disc. An epidemiologic study
with special reference to driving automobiles and cigarette
smoking.  Spine 1984, 9:608-613.
9. Ishihara H, Tsuji H, Hirano N, Ohshima H, Terahata N: Effects of
continuous quantitative vibration on rheologic and biological
behaviors of the intervertebral disc.  Spine 1992, 17(3
Suppl):S7-12.
10. Pope MH, Hansson TH: Vibration of the spine and low back
pain.  Clin Orthop Relat Res 1992, 279:49-59.
11. Battie MC, Videman T, Gill K, Moneta GB, Nyman R, Kaprio J,
Koskenvuo M: 1991 Volvo Award in clinical sciences. Smoking
and lumbar intervertebral disc degeneration: an MRI study
of identical twins.  Spine 1991, 16:1015-1021.
12. Chan D, Song Y, Sham P, Cheung KM: Genetics of disc degenera-
tion.  Eur Spine J 2006, 15:317-325.
13. Videman T, Gibbons LE, Battie MC, Maravilla K, Vanninen E, Leppa-
vuori J, Kaprio J, Peltonen L: The relative roles of intragenic pol-
ymorphisms of the vitamin d receptor gene in lumbar spine
degeneration and bone density.  Spine 2001, 26(3):E7-E12.
14. Cheung KM, Chan D, Karppinen J, Chen Y, Jim JJ, Yip SP, Ott J, Wong
KK, Sham P, Luk KD, Cheah KS, Leong JC, Song YQ: Association of
the Taq I allele in vitamin D receptor with degenerative disc
disease and disc bulge in a Chinese population.  Spine 2006,
31:1143-1138.
15. Takahashi M, Haro H, Wakabayashi Y, Kawa-uchi T, Komori H, Shi-
nomiya K: The association of degeneration of the interverte-
bral disc with 5a/6a polymorphism in the promoter of the
human matrix metalloproteinase-3 gene.  J Bone Joint Surg Br
2001, 83:491-495.
16. Guiot BH, Fessler RG: Molecular biology of degenerative disc
disease.  Neurosurgery 2000, 47:1034-1040.
17. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM:
Matrix metalloproteinases and aggrecanase: their role in dis-
orders of the human intervertebral disc.  Spine 2000,
25:3005-3013.
18. Karppinen J, Paakko E, Raina S, Tervonen O, Kurunlahti M, Nieminen
P, Ala-Kokko L, Malmivaara A, Vanharanta H: Magnetic resonance
imaging findings in relation to the COL9A2 tryptophan allele
among patients with sciatica.  Spine 2002, 27:78-83.
19. Paassilta P, Lohiniva J, Goring HH, Perala M, Raina SS, Karppinen J,
Hakala M, Palm T, Kroger H, Kaitila I, Vanharanta H, Ott J, Ala-Kokko
L: Identification of a novel common genetic risk factor for
lumbar disk disease.  JAMA 2001, 285:1843-1849.
20. Annunen S, Paassilta P, Lohiniva J, Perala M, Pihlajamaa T, Karppinen
J, Tervonen O, Kroger H, Lahde S, Vanharanta H, Ryhanen L, Goring
HH, Ott J, Prockop DJ, Ala-Kokko L: An allele of COL9A2 asso-
ciated with intervertebral disc disease.  Science 1999,
285:409-412.
21. Solovieva S, Lohiniva J, Leino-Arjas P, Raininko R, Luoma K, Ala-
Kokko L, Riihimaki H: COL9A3 gene polymorphism and obes-
ity in intervertebral disc degeneration of the lumbar spine:
evidence of gene-environment interaction.  Spine 2002,
27:2691-2696.
22. Jim JJ, Noponen-Hietala N, Cheung KM, Ott J, Karppinen J, Sahrara-
vand A, Luk KD, Yip SP, Sham PC, Song YQ, Leong JC, Cheah KS, Ala-
Kokko L, Chan D: The TRP2 allele of COL9A2 is an age-
dependent risk factor for the development and severity of
intervertebral disc degeneration.  Spine 2005, 30:2735-2742.
23. Pluijm SM, van Essen HW, Bravenboer N, Uitterlinden AG, Smit JH,
Pols HA, Lips P: Collagen type I alpha1 Sp1 polymorphism,
osteoporosis, and intervertebral disc degeneration in older
men and women.  Ann Rheum Dis 2004, 63:71-77.
24. Tilkeridis C, Bei T, Garantziotis S, Stratakis CA: Association of a
COL1A1 polymorphism with lumbar disc disease in young
military recruits.  J Med Genet 2005, 42:e44.
25. Seki S, Kawaguchi Y, Chiba K, Mikami Y, Kizawa H, Oya T, Mio F, Mori
M, Miyamoto Y, Masuda I, Tsunoda T, Kamata M, Kubo T, Toyama Y,
Kimura T, Nakamura Y, Ikegawa S: A functional SNP in CILP,
encoding cartilage intermediate layer protein, is associated
with susceptibility to lumbar disc disease.  Nat Genet 2005,
37:607-612.
26. Kawaguchi Y, Osada R, Kanamori M, Ishihara H, Ohmori K, Matsui H,
Kimura T: Association between an aggrecan gene polymor-
phism and lumbar disc degeneration.  Spine 1999,
24:2456-2460.
27. Goupille P, Jayson MI, Valat JP, Freemont AJ: Matrix metalloprotei-
nases: the clue to intervertebral disc degeneration?  Spine
1998, 23:1612-1626.
28. Grange L, Gaudin P, Trocme C, Phelip X, Morel F, Juvin R: Interver-
tebral disk degeneration and herniation: the role of metallo-
proteinased and cytokines.  Joint Bone Spine 2001, 68:547-553.
29. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ,
Brinckerhoff CE: A single nucleotide polymorphism in the
matrix metalloproteinase-1 promoter creates an Ets binding
site and augments transcription.  Cancer Res 1998,
58:5321-5325.
30. Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi
H, Romero R, Strauss JF 3rd: A single nucleotide polymorphism
in the matrix metalloproteinase-1 (MMP-1) promoter influ-
ences amnion cell MMP-1 expression and risk for preterm
premature rupture of the fetal membranes.  J Biol Chem 2002,
277:6296-6302.
31. Vincenti MP, Brinckerhoff CE: Transcriptional regulation of col-
lagenase (MMP-1, MMP-13) genes in arthritis: integration of
complex signaling pathways for the recruitment of gene-spe-
cific transcription factors.  Arthritis Res 2002, 4(3):157-64.
32. Matsui Y, Maeda M, Nakagami W, Iwata H: The involvement of
matrix metalloproteinases and inflammation in lumbar disc
herniation.  Spine 1998, 23(8):863-8.
33. Tower GB, Coon CI, Belguise K, Chalbos D, Brinckerhoff CE: Fra-1
targets the AP-1 site/2G single nucleotide polymorphism
(ETS site) in the MMP-1 promoter.  Eur J Biochem 2003,
270(20):4216-25.
34. Benbow U, Tower GB, Wyatt CA, Buttice G, Brinckerhoff CE: High
levels of MMP-1 expression in the absence of the 2G single
nucleotide polymorphism is mediated by p38 and ERK1/2Page 5 of 6
(page number not for citation purposes)
BMC Medical Genetics 2008, 9:38 http://www.biomedcentral.com/1471-2350/9/38Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
mitogen-activated protein kinases in VMM5 melanoma cells.
J Cell Biochem 2002, 86(2):307-19.
35. Tower GB, Coon CC, Benbow U, Vincenti MP, Brinckerhoff CE: Erk
1/2 differentially regulates the expression from the 1G/2G
single nucleotide polymorphism in the MMP-1 promoter in
melanoma cells.  Biochim Biophys Acta 2002, 1586(3):265-74.
36. Fosang AJ, Last K, Knauper V, Neame PJ, Murphy G, Hardingham TE,
Tschesche H, Hamilton JA: Fibroblast and neutrophil colla-
genases cleave at two sites in the cartilage aggrecan inter-
globular domain.  Biochem J 1993, 295:273-6.
37. Schneiderman G, Flannigan B, Kingston S, Thomas J, Dillin WH, Wat-
kins RG: Magnetic resonance imaging in the diagnosis of disc
degeneration: correlation with discography.  Spine 1987,
12:276-281.
38. Powell MC, Wilson M, Szypryt P, Symonds EM, Worthington BS:
Prevalence of lumbar disk degeneration observed by mag-
netic resonance in symptomless women.  Lancet 1986,
2:1366-1367.
39. Sether LA, Yu S, Haughton VM, Fischer ME: Intervertebral disk:
normal age-related changes in MR signal intensity.  Radiology
1990, 177:385-388.
40. Yu SW, Haughton VM, Ho PS, Sether LA, Wagner M, Ho KC: Pro-
gressive and regressive changes in the nucleus pulposus. Part
II. The adult.  Radiology 1988, 169:93-97.
41. Tertti M, Paajanen H, Laato M, Aho H, Komu M, Kormano M: Disc
degeneration in magnetic resonance imaging. A compara-
tive biochemical, histologic, and radiologic study in cadaver
spines.  Spine 1991, 16:629-634.
42. Hettiaratchi A, Hawkins NJ, McKenzie G, Ward RL, Hunt JE, Wake-
field D, Girolamo ND: The collagenase-I (MMP-1) gene pro-
moter polymorphism -1607/2G is associated with favourable
prognosis in patients with colorectal cancer.  Br J Cancer 2007,
96:783-92.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/9/38/prepubPage 6 of 6
(page number not for citation purposes)
